2007
DOI: 10.1523/jneurosci.2326-07.2007
|View full text |Cite
|
Sign up to set email alerts
|

Myosin Va Controls Oligodendrocyte Morphogenesis and Myelination

Abstract: A product of myosin Va mutations, Griscelli's syndrome type 1 (GS1) is characterized by several neurologic deficits including quadraparesis, mental retardation, and seizures. Although multiple studies have not clearly established a cause for the neurologic deficits linked with GS1, a few reports suggest that GS1 is associated with abnormal myelination, which could cause the neurologic deficits seen with GS1. In this report, we investigate whether myosin Va is critical to oligodendrocyte morphology and to myeli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(40 citation statements)
references
References 54 publications
0
39
0
Order By: Relevance
“…Possibly, additional redundant pathways controlled by other R-SNAREs such as VAMP2 and VAMP4 account for surface transport in oligodendrocytes. It has been shown that ablation of myosin-Va affects VAMP2 localization and functional inactivation of VAMP2 by application of blocking antibodies or treatment with TeNT (certainly also inactivating VAMP3) affects oligodendroglial process growth (Sloane and Vartanian, 2007).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Possibly, additional redundant pathways controlled by other R-SNAREs such as VAMP2 and VAMP4 account for surface transport in oligodendrocytes. It has been shown that ablation of myosin-Va affects VAMP2 localization and functional inactivation of VAMP2 by application of blocking antibodies or treatment with TeNT (certainly also inactivating VAMP3) affects oligodendroglial process growth (Sloane and Vartanian, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…toward potential myelin defects in patients suffering from diseases characterized by defects in lysosomal secretion such as Griscelli syndrome (Sloane and Vartanian, 2007).…”
Section: Role Of Vamp3 and Vamp7 In Myelinationmentioning
confidence: 99%
“…During normal development it is associated with an increased expression of myelin proteins, such as myelin basic protein (MBP) (Zeller et al, 1985;Dubois-Dalcq et al, 1986;Hardy and Friedrich, 1996). Under experimental conditions, morphological maturation of oligodendrocytes can occur in the absence of an increase in myelin gene expression, suggesting that these two events may be regulated independently from each other (Buttery and ffrenchConstant, 1999;Osterhout et al, 1999;Sloane and Vartanian, 2007). In the case of PD-Iα/ ATX's MORFO domain we currently favor a model in which primarily morphological remodeling is affected.…”
Section: Discussionmentioning
confidence: 99%
“…Ppp1r14a is a phosphorylationdependent inhibitory protein for myosin phosphatase, which regulates myosin activity by dephosphorylation of myosin light chain (Ito et al, 2004). Notably, myosin Va-null mice exhibit significantly impaired myelination in the CNS (Sloane and Vartanian, 2007), raising the possibility that Ppp1r14a regulates oligodendrocyte differentiation. Ppp1r14a can promote tumorigenesis by regulating activity of the Nf2/ Merlin tumor suppressor by means of myosin phosphatase (Jin et al, 2006).…”
Section: Validation Of Oligodendrocyte Gene Identification By In Situmentioning
confidence: 99%